 | • レポートコード：MRC2302F0017 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、240ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に192.5億ドルであった世界の心臓インターベンションデバイス市場規模が、2022年に208.8億ドルになり、2027年には316.2億ドルまで、年平均8.61%で成長すると予測しています。本レポートでは、心臓インターベンションデバイスの世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、デバイス別（血管形成ステント、カテーテル、慢性完全閉塞、塞栓保護装置、その他）分析、エンドユーザー別（外来手術センター、カテーテル検査室、病院＆医療提供者）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Abbott Laboratories、B Braun Melsungen AG、Biosensors International Pte Ltd、Biotronik Inc、Boston Scientific Corp、Cordis Corporation、CR Bard Inc.、Edwards Lifesciences Corporation、iVascular SLU、Johnson & Johnson Pvt. Ltd.、LivaNova, PLC.、Medtronic, PLC、MicroPort Medical Apparatus (Shanghai) Co. Ltd.、Teleflex Incorporated、Terumo Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の心臓インターベンションデバイス市場規模：デバイス別 - 血管形成ステントの市場規模 - カテーテルの市場規模 - 慢性完全閉塞の市場規模 - 塞栓保護装置の市場規模 - その他デバイスの市場規模 ・世界の心臓インターベンションデバイス市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - カテーテル検査室における市場規模 - 病院＆医療提供者における市場規模 ・世界の心臓インターベンションデバイス市場規模：地域別 - 南北アメリカの心臓インターベンションデバイス市場規模 アメリカの心臓インターベンションデバイス市場規模 カナダの心臓インターベンションデバイス市場規模 ブラジルの心臓インターベンションデバイス市場規模 ... - アジア太平洋の心臓インターベンションデバイス市場規模 日本の心臓インターベンションデバイス市場規模 中国の心臓インターベンションデバイス市場規模 インドの心臓インターベンションデバイス市場規模 韓国の心臓インターベンションデバイス市場規模 台湾の心臓インターベンションデバイス市場規模 ... - ヨーロッパ/中東/アフリカの心臓インターベンションデバイス市場規模 イギリスの心臓インターベンションデバイス市場規模 ドイツの心臓インターベンションデバイス市場規模 インドの心臓インターベンションデバイス市場規模 フランスの心臓インターベンションデバイス市場規模 ロシアの心臓インターベンションデバイス市場規模 ... - その他地域の心臓インターベンションデバイス市場規模 ・競争状況 ・企業情報 |
The Global Interventional Cardiology Devices Market size was estimated at USD 19.25 billion in 2021 and expected to reach USD 20.88 billion in 2022, and is projected to grow at a CAGR 8.61% to reach USD 31.62 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Interventional Cardiology Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device, the market was studied across Angioplasty Stents, Balloon Inflation Devices, Catheters, Chronic Total Occlusion, Embolic Protection Devices, Hemodynamic Flow Alteration Devices, Introducer Sheaths, PTCA balloons, Plaque Modification Devices, Vascular Closure Devices, Vascular Closure Devices, guidewires, and imaging systems. The Angioplasty Stents is further studied across Bare-Metal Stents, Bioabsorbable Stents, and Drug-Eluting Stents. The Catheters is further studied across Angiography Catheters, Guiding Catheters, and Ivus/Oct Catheters. The Hemodynamic Flow Alteration Devices is further studied across Chronic Total Occlusion Devices and Embolic Protection Devices. The Plaque Modification Devices is further studied across Atherectomy Devices and Thrombectomy Devices.
Based on End-User, the market was studied across Ambulatory Surgical Centers, Catheterization Labs, and Hospital & Care Providers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Interventional Cardiology Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Interventional Cardiology Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Interventional Cardiology Devices Market, including Abbott Laboratories, B Braun Melsungen AG, Biosensors International Pte Ltd, Biotronik Inc, Boston Scientific Corp, Cordis Corporation, CR Bard Inc., Edwards Lifesciences Corporation, iVascular SLU, Johnson & Johnson Pvt. Ltd., LivaNova, PLC., Medtronic, PLC, MicroPort Medical Apparatus (Shanghai) Co. Ltd., Teleflex Incorporated, and Terumo Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Interventional Cardiology Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Cardiology Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Cardiology Devices Market?
4. What is the competitive strategic window for opportunities in the Global Interventional Cardiology Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Interventional Cardiology Devices Market?
6. What is the market share of the leading vendors in the Global Interventional Cardiology Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Interventional Cardiology Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid growth in the geriatric population along with diabetic patients
5.1.1.2. Rising demand for minimally invasive treatment
5.1.1.3. Growing prevalence of coronary artery diseases
5.1.2. Restraints
5.1.2.1. Availability of alternative treatments
5.1.3. Opportunities
5.1.3.1. Growing untapped emerging markets in developing countries
5.1.3.2. Technological advancements in interventional cardiology devices
5.1.4. Challenges
5.1.4.1. Issues related to product failures and recalls
5.2. Cumulative Impact of COVID-19
6. Interventional Cardiology Devices Market, by Device
6.1. Introduction
6.2. Angioplasty Stents
6.3.1. Bare-Metal Stents
6.3.2. Bioabsorbable Stents
6.3.3. Drug-Eluting Stents
6.3. Balloon Inflation Devices
6.4. Catheters
6.5.1. Angiography Catheters
6.5.2. Guiding Catheters
6.5.3. Ivus/Oct Catheters
6.5. Chronic Total Occlusion
6.6. Embolic Protection Devices
6.7. Hemodynamic Flow Alteration Devices
6.8.1. Chronic Total Occlusion Devices
6.8.2. Embolic Protection Devices
6.8. Introducer Sheaths
6.9. PTCA balloons
6.10. Plaque Modification Devices
6.11.1. Atherectomy Devices
6.11.2. Thrombectomy Devices
6.11. Vascular Closure Devices
6.12. Vascular Closure Devices
6.13. guidewires
6.14. imaging systems
7. Interventional Cardiology Devices Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Catheterization Labs
7.4. Hospital & Care Providers
8. Americas Interventional Cardiology Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Interventional Cardiology Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Interventional Cardiology Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. B Braun Melsungen AG
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Biosensors International Pte Ltd
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Biotronik Inc
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Boston Scientific Corp
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Cordis Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. CR Bard Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Edwards Lifesciences Corporation
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. iVascular SLU
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Johnson & Johnson Pvt. Ltd.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. LivaNova, PLC.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Medtronic, PLC
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. MicroPort Medical Apparatus (Shanghai) Co. Ltd.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Teleflex Incorporated
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Terumo Corporation
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing